Antiagalactosyl IgG antibodies in juvenile idiopathic arthritis, juvenile onset Sjögren's syndrome, and healthy children

Journal of Rheumatology

Volumn 31, Issue 6, 2004, Pages 1211-1217

  Maeno, Nobuaki ^b   Takei, Syuji ^a   Fujikawa, Satoshi ^c   Yamada, Yuji ^d   Imanaka, Hiroyuki ^a   Hokonohara, Masashi ^b   Kawano, Yoshifumi ^a   Oda, Hiroshi ^a  

^a Department of Bacteriology ^*

^b KAGOSHIMA UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d EISAI CO LTD   (Japan)

Author keywords

Antiagalactosyl IgG antibodies; Children; Juvenile idiopathic arthritis; Rheumatoid factors; Sj gren's syndrome

Indexed keywords

AGALACTOSYL ANTIBODY; GALACTOSE; IMMUNOGLOBULIN G ANTIBODY; LECTIN; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTHRITIS; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; IDIOPATHIC DISEASE; JOINT DESTRUCTION; JUVENILE RHEUMATOID ARTHRITIS; LASER NEPHELOMETRY; MAJOR CLINICAL STUDY; ONSET AGE; POLYARTHRITIS; PRIORITY JOURNAL; PROGNOSIS; SJOEGREN SYNDROME; SYSTEMIC ARTHRITIS;

ADOLESCENT; AGE OF ONSET; ARTHRITIS, JUVENILE RHEUMATOID; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GALACTOSE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MALE; PROGNOSIS; RHEUMATOID FACTOR; SJOGREN'S SYNDROME;

EID: 2642548885     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Minden K, Kiessling U, Listing J, et al. Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy. J Rheumatol 2000;27:2256-63.
2. Cassidy JT, Levinson JE, Bass JC, et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 1986;29:274-81.
3. Gallagher KT, Bernstein B. Juvenile rheumatoid arthritis. Curr Opin Rheumatol 1999;11:372-6.
4. Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rbeumatol 1998;25:1991-4.
5. Gare BA, Fasth A. The natural history of juvenile chronic arthritis: a population based cohort study. II. Outcome. J Rheumatol 1995;22:308-19.
6. Walker SM, Shaham B, McCrudy DK, et al. Prevalence and concentration of IgM rheumatoid factor in polyarticular onset disease as compared to systemic or pauciarticular onset disease in active juvenile rheumatoid arthritis as measured by ELISA. J Rheumatol 1990;17:936-40.
7. Jarvis JN, Pousak T, Krenz M. Detection of IgM rheumatoid factors by enzyme-linked immunosorbent assay in children with juvenile rheumatoid arthritis: correlation with articular disease and laboratory abnormalities. Pediatrics 1992;90:945-9.
8. Flato B, Aasland A, Vinje O, Forre O. Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy. J Rheumatol 1998;25:366-75.
9. Anaya JM, Ogawa N, Talal N. Sjögren's syndrome in childhood. J Rheumatol 1995;22:1152-8.
10. Tomiita M, Saito K, Kohno Y, Shimojo N, Fujikawa S, Niimi H. The clinical features of Sjögren's syndrome in Japanese children. Acta Paediatr Jpn 1997;39:268-72.
11. Maeno N, Takei S, Imanaka H, et al. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children. J Rheumatol 2001;28:860-4.
12. Muller K, Oxholm P, Mier-Madsen M, Wiik A. Circulating IgA- and IgM-rheumatoid factors in patients with primary Sjögren syndrome. Correlation to extraglandular manifestations. Scand J Rheumatol 1989;18:29-31.
13. Soltys AJ, Hay FC, Bond A, et al. The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content. Scand J Immunol 1994;40:135-43.
14. Patekh RB, Dwek RA, Sutton BJ, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985;316:452-7.
15. Parekh R, Isenberg D, Rook G, Roitt I, Dwek R, Rademacher T. A comparative analysis of disease-associated changes in the galactosylation of serum IgG. J Autoimmun 1989;2:101-14.
16. Parekh RB, Roitt IM, Isenberg DA, Dwek RA, Ansell BM, Rademacher TW. Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1988;1:966-9.
17. Yamada Y, Hosoda T, Yoshizawa M, Yamane S. Development and evaluation of the lectin-enzyme immunoassay kit for detection of anti-agalactosyl IgG antibodies [in Japanese]. Kiso to Rinsyo 1997;31:81-101.
18. Ichikawa Y, Yamada C, Horiki T, et al. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis. Clin Exp Rheumatol 1998;16:709-15.
19. Nishijima C, Sato S, Takehara K. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis. J Rheumatol 2001;28:1847-51.
20. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
21. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
22. Bartunkova J, Sediva A, Vencovsky J, Tesar V. Primary Sjögren's syndrome in children and adolescents: proposal for diagnostic criteria. Clin Exp Rheumatol 1999;17:381-6.
23. Paulus HE, Wiesner J, Bulpitt KJ, et al. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment. J Rheumatol 2002;29:2513-20.
24. Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA. Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002;29:2074-6.
25. Tanaka S, Tatsumi K, Tomita T, et al. Novel autoantibodies to pituitary gland specific factor la in patients with rheumatoid arthritis. Rheumatology Oxford 2003;42:353-6.
26. Li CG, Reynolds I, Ponting JM, Holt PJ, Hillarby MC, Kumar S. Serum levels of vascular endothelial growth factor (VEGF) are markedly elevated in patients with Wegener's granulomatosis. Br J Rheumatol 1998;37:1303-6.
27. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989;96:68-73.
28. Parekh R, Roitt I, Isenberg D, Dwek R, Rademacher T. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med 1988;167:1731-6.
29. Yamada E, Tsukamoto Y, Sasaki R, Yagyu K, Takahashi N. Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconj J 1997;14:401-5.
30. Uchida S, Nishimura K, Kuga Y, et al. Clinical significance of the anti-agalactosyl IgG antibody detection for the diagnosis of rheumatoid arthritis [in Japanese]. Ryumachi Ka 1997;17:328-33.
31. Sailer M, Cabral D, Petty RE, Malleson PN. Rheumatoid factor positive, oligoarticular onset juvenile rheumatoid arthritis. J Rheumatol 1997;24:586-8.